Table 1.
Individual | III-1 | II-2 | III-4 | III-6 |
---|---|---|---|---|
Family | family A | family B | family C | family C |
Mutation | ||||
Allele 1 | c.395C>T (p.Pro132Leu) | c.1859−119G>A (p.Ser620delins40) | c.1969+115_1969+116del (p.Pro658Serfs∗24) | |
Allele 2 | c.1441C>T (p.Gln481∗) | c.1879_1881del (p.Lys627del) | = Allele 1 | |
Demographics | ||||
Sex | male | female | female | male |
Age at the last visit | 4 years 10 months | 37 years | 23 years | 14 years |
Ethnic background | Brazilian | Japanese | Chaldean | Chaldean |
Consanguinity | – | – | + | + |
Gestational/Perinatal Record | ||||
Fetal ultrasound | Dandy-Walker complex | normal | N/A | hydrocephalus |
Gestational age | 37 5/7 weeks | N/A | full term | full term |
Birth weight (g) | 4,270 (>90th centile) | N/A | N/A | 3,300 |
Birth length (cm) | 50 (75–90th centile) | N/A | N/A | N/A |
OFC (cm) | 40 (>98th centile) | N/A | normal | normal |
Skeletal Radiograph | ||||
Fracture | – | + | – | – |
Skull sclerosis | + | + | + | + |
Optic canal narrowing | + | + | – | – |
Pelvic bone sclerosis | + | + | – | – |
Vertebral sclerosis | + | + | – | – |
Platyspondyly | + | + concaved at posterior thirds | + | + |
Tubular bones | ||||
Under-modeling | + | + | + | + |
Widened metaphysis | + | + | + | + |
Radiolucent metaphysis | + | + | + | + |
Constricted diaphysis | + | + | + | + |
Sclerotic diaphysis | + | + | + | + |
Brain Imaging | ||||
Multiple calcifications | + | + | + | + |
Stepping stone appearance (peri-callosal region) | + | + | − | − |
Corpus callosum agenesis | + | – | – | – |
Dilated ventricle | + | + | + | + |
Hydrocephalus | + congenital | – | – | + congenital |
Dandy-Walker complex | + | – | large cysterna magna | large cysterna magna |
Abnormal white matter signal | + | + | + | + |
Laboratory Examination | ||||
Complete blood count | normal | normal | normal | normal |
Serum marker for bone metabolism | ||||
TRACP-5b | 240 (170–590 mU/dl)a | 262 (120–420 mU/dl)b | N/A | N/A |
CTX | 282 (155–873 pg/mL)c | N/A | WNL | WNL |
NTX | N/A | 9.1 (7.5–16.5 nmol BCE/l)d | WNL | WNL |
Abbreviations: N/A, not available; OFC, occipitofrontal circumference; TRACP-5b, tartrate-resistant acid phosphatase-5b; CTX, C-terminal telopeptide; NTX, type I collagen cross-linked N-telopeptides; BCE, bone collagen equivalents; WNL, within normal limits.
Normal range for male.
Normal range for female.
Normal range for male at age 18–30, the index at age less than 18 is not established.
Normal range for premenopausal female.